Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Heat shock protein family B member 3 (HSPB3) is a small heat shock protein primarily expressed in skeletal and cardiac muscle but also found in smooth muscle and the nervous system[3]. It acts as a molecular chaperone with moderate activity and is particularly important for muscle cell differentiation by regulating nuclear events and maintaining dynamic states of the lamin B receptor (LBR) and associated chromatin structure[1]. HSPB3 functions by binding to specific substrates and prevents their aggregation under cellular stress, thus supporting proteostasis and cytoskeletal integrity[2][3]. It forms oligomeric complexes (such as trimers and tetramers, and hetero-oligomers with HSPB2) and is developmentally regulated, especially upregulated during myoblast differentiation and in response to proteotoxic stress rather than heat shock[1][2][3]. Pathogenic mutations in HSPB3 are associated with neuromuscular diseases manifesting as impaired muscle differentiation, myopathies, and axonal motor neuropathies due to dominant-negative effects and misregulation of nuclear protein quality control[1][3]. *Note: No drugs directly targeting HSPB3, mechanisms of action for inhibitors/modulators, or established biomarker/safety use were found in the supplied literature as of this search. The protein is a specialized chaperone rather than a classic receptor, enzyme, or transporter drug target.*
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heat shock protein family B member 3 (HSPB3).